drugset
drugset / Trial / NCT04358770

Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

NCT04358770 ↗

Phase 1 Completed 124 enrolled Sun Pharmaceutical Industries, Inc. WAYCro · collab
RandomizedSingle-groupOpen-labelHealth-services research

Summary

To compare pharmacodynamic vasoconstriction response profile of Clocortolone Pivalate 0.1% Cream and Cloderm® (Clocortolone Pivalate) 0.1% Cream in normal skin of healthy male and female adults

Timeline

Start
2018-03-02
Primary completion
2018-04-27
Completion
2018-05-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clocortolone Pivalate Small molecule 0.1 % Topical

Indications

No indication recorded.